1999
DOI: 10.1002/(sici)1099-1557(199904)8:1+<s1::aid-pds401>3.3.co;2-5
|Get access via publisher |Summarize |Cite
The role of pharmacoepidemiology in pharmacovigilance: a conference at the 6th ESOP Meeting, Budapest, 28 September 1998
Search citation statements
Paper Sections
Select...
10
1
0
0
Citation Types
0
1
0
0
Year Published
2001
2015
Publication Types
Select...
11
Relationship
1
10
Authors
Journals
Cited by 11 publications
(1 citation statement)
References 0 publications
0
1
0
0
“…For events where the hazard is constant over time, such as the typical dose and duration‐dependent pharmacological type A adverse effects (Figure , curve A), the instant hazard function curve is flat . Cumulative risk increases linearly with exposure, as evident for the Gastrointestinal (GI) risk found in the Vigor study, or the cardiovascular risk in Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial .…”
Section: Discussionmentioning
confidence: 99%
“…For events where the hazard is constant over time, such as the typical dose and duration‐dependent pharmacological type A adverse effects (Figure , curve A), the instant hazard function curve is flat . Cumulative risk increases linearly with exposure, as evident for the Gastrointestinal (GI) risk found in the Vigor study, or the cardiovascular risk in Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial .…”
Section: Discussionmentioning
confidence: 99%
